Random serum transferrin saturation (TS) was measured in 1194 patients attending a diabetic clinic. Twenty-one patients had TS> 55070 and in three of these patients repeat random TS was < 55070. Seventeen patients were recalled for fasting serum TS and ferritin measurement. Ten patients had fasting TS> 55%. The diagnosis of haemochromatosis was confirmed by liver biopsy in a total of six patients, three of whom were previously unsuspected. Haemochromatosis was the possible diagnosis in a further four patients. Family studies using HLA typing confirmed haemochromatosis in four family members, three of whom were asymptomatic. We conclude that measurement of TS is a simple and effective method of finding cases of haemochromatosis in the diabetic clinic.
Hereditary haemochromatosis (HH) is an autosomal recessive disorder of iron metabolism." The defective gene lies close to the histocompatibility locus antigen (HLA) on the short arm of chromosome 6. 2 Untreated, homozygotes for the disorder absorb excessive amounts of iron which is deposited in various organs and can eventually lead to the clinical signs and symptoms of the disease such as heart failure, cirrhosis, arthritis, pigmentation and diabetes. ' The prevalence of HH may be as high as 4· 5 per 1000,4 one of the commonest autosomal recessive disorders. Not all homozygotes, however, will absorb sufficient iron to become symptomatic. Clinical haemochromatosis develops five times more frequently in men than in women, even though the male: female ratio for homozygosity is the same. It is likely that most cases of haemochromatosis are not diagnosed during life. 5 Although HH fulfils the classic criteria of a medical condition suitable for screening, no screening programme exists in the UK and there may be formidable obstacles to the establishment of such a programme in the healthy population."
Diabetes is a condition classically associated with HH. In addition to the effect of iron deposition in the pancreatic islet beta cells there may also be a genetic link between the two Correspondence; Dr R M Evans, Biochemistry Department. conditions which would explain the frequent occurrence of diabetes in the siblings of patients with haemochromatosis and diabetes." The diabetes in haemochromatotic patients is similar to other patients with type II diabetes, with normal or exaggerated glucagon response but impaired insulin response to glucose." Depending on the population studied, between 20% and 80% of cases of HH have diabetes rnellitus.P-'? and therefore screening the diabetic population is likely to result in finding new cases of HH. Subsequent investigation of family members of these cases is likely to be successful, because these individuals may be motivated to participate since they have been exposed to morbidity due to the condition in one of their relatives. However, there have been conflicting reports regarding the prevalence of haemochromatosis in diabetics with reported prevalence varying from O·5% to 3·1 %.9,11-13 Some authors suggest that screening of diabetics may be cost effective.l'v" and others have argued that such testing is not routinely necessary.v"
The percentage saturation of serum transferrin, preferably in the fasting state, is the most effective screening test for HH. 4 ,6 We measured serum transferrin saturation (TS) in patients attending a diabetic clinic in order to estimate the prevalence of HH. When TS was elevated follow up studies were performed. a During the four month study period, 1194 diabetics were screened, 657 males (median age 57, range 14-88), and 537 females (median age 60, range 14-92). The distribution of random TS is shown in Fig. I . Women had a lower TS than men. Twenty-one of the 1194 diabetics had a random TS greater than 55%. Three of these had a repeat random TS less than 55% and were not studied further. One patient died at another hospital before a repeat fasting sample could be measured. Ten of the remaining 17 patients had a fasting TS greater than 55%. The biochemical and histological characteristics of these 10 patients are shown in Table I . Cases I and 2 were already known to suffer from HH, the diagnosis having been made on clinical grounds, iron overload on liver biopsy and response to venesection therapy. Another patient with random TS less than 55% was also known to have HH based on clinical features, liver biopsy appearances and response to venesection. She had received venesection treatment for many years prior to our study, and had also developed ulcerative colitis.
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Six of the IO patients with fasting TS greater than 55% had raised SF and all six consented to liver biopsy. Cases 3, 4 and 5 were new cases of HH, the diagnosis based on histological appearance and hepatic iron index of greater than 2. 15 All patients attending diabetic clinics in our area between October 1992 and January 1993 were studied. The aims of the study were explained to the patients in an information leaflet and an extra blood sample taken for measurement of random TS. All patients with a random TS greater than 5511,10 were contacted by letter and requested to attend for measurement of fasting TS and serum ferritin (SF). Further explanation of the study was given at this time and a clinical examination was performed.
If the fasting TS was greater than 55% and the SF was elevated (males greater than 300 p.g/L, females greater than 200 p.g/L) the patient was requested to attend for liver biopsy. Liver biopsy was performed using a Menghini needle with no more than two passes performed in order to obtain adequate tissue for analysis. Providing sufficient material was obtained, the sample was divided for histological and biochemical examination. In addition to standard histological assessment, the liver tissue was stained with Perls' stain and iron graded by a modified Scheuer method;" For measurement of the liver iron content, liver biopsies were dried, weighed and dissolved in nitric acid. The iron in the digest was measured by flame atomic absorption spectrometry. As quality control, iron in a certified reference material, BCR bovine liver 185, was measured with each batch. The liver iron content was expressed as the hepatic iron index (HIl) by dividing the iron content in p.mollg dry weight by the age of the patient in years."
Serum iron was measured using a ferrozine colorometric method (Mast Diagnostic Ltd, Bootie, UK) on a Bayer RA-lOOO analyser (Bayer Pic, Basingstoke, UK) and serum transferrin was measured by rate nephelometry on a Beckman Array analyser using Beckman anti-serum (Beckman-RIIC Ltd, High Wycombe, UK). Transferrin saturation was calculated using the formula:
Serum ferritin was measured using an immunoradiometric assay (Ferritin MAB-Becton Dickinson UK Ltd, Oxford, UK).
In all new cases of haemochromatosis, first degree relatives were invited to attend for investigations which included HLA typing, fasting TS and SF measurements. *Haemochromatosis diagnosed prior to the study. There was also one previously diagnosed and treated case whose transferrin saturation was less than 55% during the study. Liver biopsy showed Scheuer grade 3, and 40 units of blood had been withdrawn by venesection.
and clinical history. Cases 7 and 8 have some degree of increased liver iron stores but HH could not be confirmed by hepatic iron index. Cases 9 and 10 had serum ferritin within the reference range and therefore did not qualify for liver biopsy. However, HH could not be excluded in cases 7-10 and these patients are being followed with annual SF analyses to see if they show evidence of increasing iron stores. Thus, there were six definite cases and four possible cases of haemochromatosis in our diabetic population. In all cases, the age of onset of diabetes was greater than 40 years. Family studies of the newly diagnosed cases revealed four individuals who had HLA type identical to the proband. All of these had fasting TS of over 55070, but only one had a raised SF. Her liver biopsy confirmed the diagnosis of HH. The other three are being followed up with annual SF measurement.
DISCUSSION
Of the four studies on the prevalence of haemochromatosis in diabetes in the world literature, 9. 1 J -13 two recommend testing of diabetics for haemochromatosis!'-'? and two suggest that such testing would not be useful. 9 , l3 O'Brien et al.? rejected screening diabetics on the grounds that two out of three cases of newly diagnosed HH had other clinical markers of the condition. In that study 13 patients out of a clinic of 572 diabetics over the age of 30 may have been previously diagnosed as having HH. Clearly this centre had a high level of awareness for HH, and their findings might not be matched in a clinic without a special interest. Singh et al. 13 argued that the prevalence of HH was no greater than in the non-diabetic population. In that study, two new cases were found in a population of 406, a prevalence of 5/1000. However, an accurate comparison of the prevalence of HH in diabetic and non-diabetic populations is made difficult by the differences in criteria used for the diagnosis of HH. 9 ,11-13, 16-24 Although there is evidence that hepatic iron index of greater than 2 is the best discriminator," few studies have reported this parameter. Table 2 shows estimates of the prevalence of HH in diabetic and nondiabetic populations from several studies using various diagnostic criteria. Accurate comparisons are also made difficult by variations in the population studied and screening tests used. Blood donation, iron fortification of the diet" and liver damage due to hepatitis Band C infectiorr'! are all factors which may result in different degrees of clinical and biochemical expression. For example, in a study of 11 065 blood donors,'? 17 of 24 subjects with pre-clinical haemochromatosis had a hepatic iron index of less than 2, the lowest value being O· 35, and a study of male Second World War veterans aged 58 and over who had a high mean alcohol intake showed a high prevalence of clinical haemochrornatosis.!' *Method X = family study with likelihood analysis; Method A = elevated serum ferritin and transferrin saturation;
Method B = characteristic pattern of iron overload on liver biopsy; Method C = Quantitative increase in parenchymal iron (Scheuer grade 2 or more); Method D = hepatic iron index> 2 or > 4 g iron removed at phlebotomy. Prevalence figures calculated from original data using above mentioned diagnostic criteria. 'Depending on how many of 13 previously diagnosed cases of haemochromatosis were part of the study population. Ipresent study.
However, if the same diagnostic criteria are used the prevalence of HH in diabetes tends to be higher than in non-diabetic populations. For example, if a histological Scheuer grading of 2 or more is used as the diagnostic criterion then the prevalence was 6·7/ WOO in our study compared with 1·4/1000 in blood donors." However, direct statistical comparison between diabetic and non-diabetic groups is difficult as large numbers would be required in the study groups (tens of thousands) to produce narrow confidence intervals.
It is possible that the prevalence of presymptomatic HH in diabetics is the same as in the normal population and that any increase Ann Clin Biochem 1995: 32 in overall prevalence can be accounted for by cases of HH with other clinical features. Indeed, in the three cases of newly diagnosed HH some recognized features of haemochromatosis (hepatomegaly, chronic fatigue or arthralgia of the second and third metacarpophalangeal joints) were present but these had not been noticed in the busy diabetic clinic.
In these new cases, where hepatic cirrhosis is established, life expectancy is decreased but venesection may lead to an improvement in the sense of well-being, and the clinical manifestations of cardiac and hepatic damage are less common." There is also evidence that diabetic control can be improved."
Family studies revealed cases of pre-cirrhotic and pre-clinical HH and these subjects are being followed up. These cases are likely to have normal life expectancy.v-" However, the main benefit of screening diabetics for HH as opposed to the general population will be a high response rate as diabetics will be more likely to offer themselves for testing and comply with further investigation and management, thus avoiding the many pitfalls associated with screening a totally asymptomatic population."
Our study confirmed that a random TS > 55070 gave few false positives and the positive predictive value was between 24% and 43% depending on the eventual outcome. The use of cut-off value of 55% might be associated with a small number of false negatives," particularly in women where menstruation protects against iron overload. However, lowering the cut-off point by 5% or 10% would result in a marked decrease of specificity, with no guaranteed increase in sensitivity."
